↓ Skip to main content

Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial

Overview of attention for article published in Cancer (0008543X), June 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
25 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Differential prognostic effect of systemic inflammation in patients with non–small cell lung cancer treated with immunotherapy or chemotherapy: A post hoc analysis of the phase 3 OAK trial
Published in
Cancer (0008543X), June 2022
DOI 10.1002/cncr.34348
Pubmed ID
Authors

Alessio Cortellini, Biagio Ricciuti, Hossein Borghaei, Abdul Rafeh Naqash, Antonio D'Alessio, Claudia A. M. Fulgenzi, Alfredo Addeo, Giuseppe L. Banna, David James Pinato

X Demographics

X Demographics

The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 42 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 14%
Student > Ph. D. Student 4 10%
Other 4 10%
Student > Doctoral Student 3 7%
Student > Bachelor 3 7%
Other 7 17%
Unknown 15 36%
Readers by discipline Count As %
Medicine and Dentistry 12 29%
Pharmacology, Toxicology and Pharmaceutical Science 4 10%
Nursing and Health Professions 3 7%
Biochemistry, Genetics and Molecular Biology 2 5%
Unspecified 1 2%
Other 4 10%
Unknown 16 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#1,568,603
of 25,392,582 outputs
Outputs from Cancer (0008543X)
#1,296
of 14,100 outputs
Outputs of similar age
#35,327
of 444,112 outputs
Outputs of similar age from Cancer (0008543X)
#26
of 134 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 14,100 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,112 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 134 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.